Logo image of CSOD

Cornerstone Ondemand (CSOD) Stock Fundamental Analysis

NASDAQ:CSOD - Nasdaq -

57.49  +0.01 (+0.02%)

After market: 57.51 +0.02 (+0.03%)

Fundamental Rating

2

Overall CSOD gets a fundamental rating of 2 out of 10. We evaluated CSOD against 282 industry peers in the Software industry. CSOD has a bad profitability rating. Also its financial health evaluation is rather negative. CSOD shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CSOD was profitable.

1.2 Ratios

Industry RankSector Rank
ROA -1.36%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 2.83%
PM (TTM) -3.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

There is no outstanding debt for CSOD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CSOD has an Altman-Z score of 1.08. This is a bad value and indicates that CSOD is not financially healthy and even has some risk of bankruptcy.
CSOD has a Debt/Equity ratio of 3.45. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 3.45
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

CSOD has a Current Ratio of 0.68. This is a bad value and indicates that CSOD is not financially healthy enough and could expect problems in meeting its short term obligations.
CSOD has a Quick Ratio of 0.68. This is a bad value and indicates that CSOD is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.32% over the past year.
The Earnings Per Share has been growing by 100.57% on average over the past years. This is a very strong growth
The Revenue has grown by 31.95% in the past year. This is a very strong growth!
CSOD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.88% yearly.
EPS 1Y (TTM)88.32%
EPS 3Y63.13%
EPS 5Y100.57%
EPS Q2Q%82.5%
Revenue 1Y (TTM)31.95%
Revenue growth 3Y15.41%
Revenue growth 5Y16.88%
Sales Q2Q%16.26%

3.2 Future

Based on estimates for the next years, CSOD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.25% on average per year.
The Revenue is expected to grow by 9.48% on average over the next years. This is quite good.
EPS Next Y43.2%
EPS Next 2Y24.04%
EPS Next 3Y15.52%
EPS Next 5Y10.25%
Revenue Next Year18.09%
Revenue Next 2Y12.63%
Revenue Next 3Y11.24%
Revenue Next 5Y9.48%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSOD Yearly Revenue VS EstimatesCSOD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CSOD Yearly EPS VS EstimatesCSOD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CSOD is valuated rather expensively with a Price/Earnings ratio of 22.28.
Compared to an average S&P500 Price/Earnings ratio of 27.21, CSOD is valued at the same level.
Based on the Price/Forward Earnings ratio of 20.99, the valuation of CSOD can be described as rather expensive.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.70, CSOD is valued at the same level.
Industry RankSector Rank
PE 22.28
Fwd PE 20.99
CSOD Price Earnings VS Forward Price EarningsCSOD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.92
CSOD Per share dataCSOD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSOD's earnings are expected to grow with 15.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.52
PEG (5Y)0.22
EPS Next 2Y24.04%
EPS Next 3Y15.52%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CSOD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Cornerstone Ondemand

NASDAQ:CSOD (10/14/2021, 8:39:27 PM)

After market: 57.51 +0.02 (+0.03%)

57.49

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)03-01 2022-03-01/amc
Inst Owners0.76%
Inst Owner Change0%
Ins Owners2.1%
Ins Owner Change0%
Market Cap3.84B
Analysts70
Price Target61.3 (6.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.28
Fwd PE 20.99
P/S 4.62
P/FCF N/A
P/OCF N/A
P/B 12.44
P/tB N/A
EV/EBITDA 25.92
EPS(TTM)2.58
EY4.49%
EPS(NY)2.74
Fwd EY4.76%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.43
BVpS4.62
TBVpSN/A
PEG (NY)0.52
PEG (5Y)0.22
Profitability
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 2.83%
PM (TTM) -3.26%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 3.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z 1.08
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.32%
EPS 3Y63.13%
EPS 5Y100.57%
EPS Q2Q%82.5%
EPS Next Y43.2%
EPS Next 2Y24.04%
EPS Next 3Y15.52%
EPS Next 5Y10.25%
Revenue 1Y (TTM)31.95%
Revenue growth 3Y15.41%
Revenue growth 5Y16.88%
Sales Q2Q%16.26%
Revenue Next Year18.09%
Revenue Next 2Y12.63%
Revenue Next 3Y11.24%
Revenue Next 5Y9.48%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A